Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"6,600 (5,108, 8,205)","51.3% (36.5%, 63.3%)","73.0% (58.7%, 87.5%)","16.9% (11.2%, 25.1%)","95.5% (93.0%, 97.0%)","12.8 (9.1, 15.8)","18.2 (14.7, 21.9)","4.2 (2.8, 6.3)","23.9 (23.3, 24.2)",,,,,
"(p=None, None), q=(None, None), c=0.500)","6,853 (5,295, 8,417)","63.2% (47.5%, 79.6%)","68.9% (54.1%, 83.9%)","15.3% (10.2%, 23.2%)","96.5% (94.0%, 97.9%)","15.8 (11.9, 19.9)","17.2 (13.5, 21.0)","3.8 (2.5, 5.8)","24.1 (23.5, 24.5)","3.8% (1.0%, 7.6%)","23.5% (6.9%, 49.1%)","-5.8% (-9.8%, -2.7%)","-9.7% (-16.6%, -4.6%)","1.0% (-1.1%, 3.3%)"
"(p=None, None), q=(None, None), c=0.750)","7,014 (5,399, 8,626)","64.3% (47.6%, 79.6%)","67.7% (52.8%, 84.0%)","14.7% (9.7%, 22.5%)","96.6% (94.3%, 98.2%)","16.1 (11.9, 19.9)","16.9 (13.2, 21.0)","3.7 (2.4, 5.6)","24.1 (23.6, 24.5)","6.3% (2.1%, 11.4%)","25.8% (6.9%, 55.6%)","-7.5% (-12.6%, -3.3%)","-13.0% (-20.9%, -6.8%)","1.1% (-0.8%, 3.4%)"
"(p=None, None), q=(None, None), c=1.000)","7,185 (5,452, 8,836)","64.7% (47.6%, 79.6%)","66.6% (51.4%, 82.7%)","14.2% (9.2%, 21.7%)","96.6% (94.3%, 98.0%)","16.2 (11.9, 19.9)","16.7 (12.8, 20.7)","3.5 (2.3, 5.4)","24.1 (23.6, 24.5)","8.9% (3.3%, 16.3%)","26.7% (7.0%, 50.3%)","-9.0% (-15.8%, -4.1%)","-16.0% (-24.9%, -8.8%)","1.1% (-1.0%, 3.2%)"
